GarcÃa-Hernández, N.; Calzada, F.; Bautista, E.; Sánchez-López, J.M.; Valdes, M.; Hernández-Caballero, M.E.; Ordoñez-Razo, R.M.
Quantitative Proteomics and Molecular Mechanisms of Non-Hodgkin Lymphoma Mice Treated with Incomptine A, Part II. Pharmaceuticals 2025, 18, 242.
https://doi.org/10.3390/ph18020242
AMA Style
GarcÃa-Hernández N, Calzada F, Bautista E, Sánchez-López JM, Valdes M, Hernández-Caballero ME, Ordoñez-Razo RM.
Quantitative Proteomics and Molecular Mechanisms of Non-Hodgkin Lymphoma Mice Treated with Incomptine A, Part II. Pharmaceuticals. 2025; 18(2):242.
https://doi.org/10.3390/ph18020242
Chicago/Turabian Style
GarcÃa-Hernández, Normand, Fernando Calzada, Elihú Bautista, José Manuel Sánchez-López, Miguel Valdes, Marta Elena Hernández-Caballero, and Rosa MarÃa Ordoñez-Razo.
2025. "Quantitative Proteomics and Molecular Mechanisms of Non-Hodgkin Lymphoma Mice Treated with Incomptine A, Part II" Pharmaceuticals 18, no. 2: 242.
https://doi.org/10.3390/ph18020242
APA Style
GarcÃa-Hernández, N., Calzada, F., Bautista, E., Sánchez-López, J. M., Valdes, M., Hernández-Caballero, M. E., & Ordoñez-Razo, R. M.
(2025). Quantitative Proteomics and Molecular Mechanisms of Non-Hodgkin Lymphoma Mice Treated with Incomptine A, Part II. Pharmaceuticals, 18(2), 242.
https://doi.org/10.3390/ph18020242